We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.42%
5 Consumer Discretionary 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAM
2176
DELISTED
Ambrx Biopharma Inc
AMAM
-330,949
Closed -$4.71M
EXPR
2177
DELISTED
Express, Inc.
EXPR
-59
Closed -$494
ICVX
2178
DELISTED
Icosavax, Inc. Common Stock
ICVX
-2,613
Closed -$41.2K
AESC
2179
DELISTED
The AES Corporation
AESC
-45,336
Closed -$3.45M
ESMT
2180
DELISTED
EngageSmart, Inc.
ESMT
-973
Closed -$22.3K
ORTX
2181
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-869,327
Closed -$14.3M
MRTX
2182
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-1,440
Closed -$84.6K
SRC
2183
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-15,913
Closed -$695K
SLGC
2184
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-9,498
Closed -$24K
LTHM
2185
DELISTED
Livent Corporation
LTHM
-481,560
Closed -$8.66M
RPT
2186
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
-3,465
Closed -$44.5K
MACK
2187
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
-85
Closed -$1.14K
EGLE
2188
DELISTED
Eagle Bulk Shipping Inc.
EGLE
-8,698
Closed -$482K
HIBB
2189
DELISTED
Hibbett, Inc. Common Stock
HIBB
-189
Closed -$13.6K
VSTO
2190
DELISTED
Vista Outdoor Inc.
VSTO
-93
Closed -$2.75K
DOC
2191
DELISTED
PHYSICIANS REALTY TRUST
DOC
-2,055,101
Closed -$27.4M

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.